Cardiovascular Disease in Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review

O Leiva, G Hobbs, K Ravid, P Libby - Cardio Oncology, 2022 - jacc.org
Myeloproliferative neoplasms are associated with increased risk for thrombotic
complications. These conditions most commonly involve somatic mutations in genes that …

Cardiovascular Disease in Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review

O Leiva, G Hobbs, K Ravid… - JACC …, 2022 - pubmed.ncbi.nlm.nih.gov
Myeloproliferative neoplasms are associated with increased risk for thrombotic
complications. These conditions most commonly involve somatic mutations in genes that …

[HTML][HTML] Cardiovascular Disease in Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review

O Leiva, G Hobbs, K Ravid, P Libby - JACC: CardioOncology, 2022 - ncbi.nlm.nih.gov
Myeloproliferative neoplasms are associated with increased risk for thrombotic
complications. These conditions most commonly involve somatic mutations in genes that …

[HTML][HTML] Cardiovascular Disease in Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review

O Leiva, G Hobbs, K Ravid, P Libby - JACC: CardioOncology, 2022 - Elsevier
Myeloproliferative neoplasms are associated with increased risk for thrombotic
complications. These conditions most commonly involve somatic mutations in genes that …

Cardiovascular Disease in Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review.

O Leiva, G Hobbs, K Ravid, P Libby - JACC. Cardiooncology, 2022 - europepmc.org
Myeloproliferative neoplasms are associated with increased risk for thrombotic
complications. These conditions most commonly involve somatic mutations in genes that …